Epilepsy in KBG syndrome

Dev Med Child Neurol. 2023 May;65(5):712-720. doi: 10.1111/dmcn.15428. Epub 2022 Oct 4.

Abstract

Aim: To illustrate the epileptological and electroencephalographic (EEG) characteristics of a cohort of patients with KBG syndrome and epilepsy.

Method: Clinical history, age at epilepsy onset, seizure types, EEG findings, duration of epilepsy, and response to therapies were retrospectively reviewed in 11 patients (three females, eight males) with KBG syndrome.

Results: All detected genetic mutations were pathogenic and affected the C-terminal region at exon 9 of ANKRD11. One patient had 16q24.3 microdeletion including the ANKRD11 gene. Mean age at onset was 67 months. Epilepsy type was focal in five patients and generalized in four. Two patients had developmental and epileptic encephalopathies. Seizure freedom was obtained after a period varying between 15 days and 6 years.

Interpretation: In our patients, epilepsy appeared to respond well to treatment and, in some cases, to be self-limiting. The molecular characteristics of our patients' genetic abnormalities did not point towards any specific epilepsy hot spot. Epilepsy should be considered in the diagnostic work-up of patients with KBG syndrome.

What this paper adds: Some of the epilepsy types of KBG syndrome appear to be self-remitting. The epilepsy phenotypes associated with KBG syndrome are quite variable.

Publication types

  • Case Reports

MeSH terms

  • Abnormalities, Multiple* / diagnosis
  • Bone Diseases, Developmental* / diagnosis
  • Bone Diseases, Developmental* / genetics
  • Chromosome Deletion
  • Epilepsy, Generalized*
  • Facies
  • Female
  • Humans
  • Intellectual Disability* / diagnosis
  • Male
  • Phenotype
  • Repressor Proteins / genetics
  • Retrospective Studies
  • Tooth Abnormalities* / diagnosis
  • Tooth Abnormalities* / genetics

Substances

  • Repressor Proteins

Supplementary concepts

  • KBG syndrome